These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22508141)

  • 1. Use of sirolimus in patients with primary steroid-resistant nephrotic syndrome.
    Liern M; De Reyes V; Fayad A; Vallejo G
    Nefrologia; 2012 May; 32(3):321-8. PubMed ID: 22508141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F; Ahmad TM; Anwar S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
    Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
    J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
    Sozeri B; Mir S; Mutlubas F; Sen S
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
    Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
    Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of steroid-unresponsive nephrotic syndrome.
    Del Rio M; Kaskel F
    Curr Opin Pediatr; 2008 Apr; 20(2):151-6. PubMed ID: 18332710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH; Fisher M; Neale TJ
    N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
    Stiles KP; Abbott KC; Welch PG; Yuan CM
    Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
    Tumlin JA; Miller D; Near M; Selvaraj S; Hennigar R; Guasch A
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):109-16. PubMed ID: 17699197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
    Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
    Salomon R; Gagnadoux MF; Niaudet P
    Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome.
    Ulinski T
    Curr Opin Organ Transplant; 2010 Oct; 15(5):628-32. PubMed ID: 20733489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.